NCT03523026

Brief Summary

The aim of this study is to investigate the effects of peripheral and respiratory muscle training on respiratory muscle strength, respiratory functions, exercise capacity and quality of life in coronary artery patients with metabolic syndrome. Prospectively, randomly, double-blind, and controlled study. Stable coronary artery patients with metabolic syndrome will be included to the study from the Istanbul University Cardiology Institute clinic. Patients will be randomized into 3 groups; Neuromuscular Electrical Stimulation (NMES) and Peripheral Muscle Training Group (n: 20): 3 days per week for 6 weeks duration. Peripheral Muscle Training will be applied by elastic band and Proprioceptive Neuromuscular Facilitation three times per week for 6 weeks.Inspirator Muscle Training (IMT) and peripheral muscle training Group (n: 20): IMT will be applied 7 days per week, twice a day for 15 minutes. The program will continue for 6 weeks duration under weekly control of the investigator. Training intensity will set at 30% of the maximum inspiratory pressure.Peripheral Muscle Training will be applied by elastic band and Proprioceptive Neuromuscular Facilitation three times per week for 6 weeks. Peripheral Muscle Training Group (n: 20): Exercise will be applied by elastic band and Proprioceptive Neuromuscular Facilitation three times per week for 6 weeks.Parameters will be recorded before and after training. Evaluation parameters:Demographic and anthropometric measurements, respiratory function test,respiratory muscle strength,dyspnea, peripheral muscle strength, 6 minutes walking test, physical activity, quality of life, depression, sleep quality and laboratory evaluation.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Apr 2018

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 14, 2018

Completed
1 day until next milestone

Study Start

First participant enrolled

April 15, 2018

Completed
29 days until next milestone

First Posted

Study publicly available on registry

May 14, 2018

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 30, 2018

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2018

Completed
Last Updated

January 29, 2019

Status Verified

September 1, 2018

Enrollment Period

8 months

First QC Date

April 14, 2018

Last Update Submit

January 26, 2019

Conditions

Keywords

Metabolic SyndromeCoronary Artery PatientsNeuromuscular Electrical StimulationRespiratory Muscle TrainingPeripheral Muscle Training

Outcome Measures

Primary Outcomes (3)

  • Maximum Inspiratory Pressure (MIP)

    Change from baseline Maximum Inspiratory Pressure (MIP) at 6 weeks. Respiratory muscle strength will be measured according to the portable, electronic intraoral pressure measuring device (MicroRPM, Micro Medical UK), American Thoracic Society (ATS) and European Respiratory Society (ERS) criteria. The most commonly used method for evaluating respiratory muscles is MIP measurement is a non-invasive technique.

    Baseline and 6 weeks

  • Maximum Expiratory Pressure (MEP)

    Change from baseline Maximum Expiratory Pressure (MEP) at 6 weeks. Respiratory muscle strength will be measured according to the portable, electronic intraoral pressure measuring device (MicroRPM, Micro Medical UK), American Thoracic Society (ATS) and European Respiratory Society (ERS) criteria. The most commonly used method for evaluating respiratory muscles is MEP measurement is a non-invasive technique.

    Baseline and 6 weeks

  • Functional capacity

    Change from baseline functional capacity test at 6 weeks. Functional capacity will be assessed by the 6 minute walking test. The test will be performed according to American Thoracic Society (ATS) criteria. Patients will be allowed to rest for 10 minutes before the test. Heart rate, blood pressure, respiratory frequency, oxygen saturation, fatigue and dyspnea perception will be recorded before and after the test. Walking distance will be calculated.

    Baseline and 6 weeks

Secondary Outcomes (27)

  • Forced Vital Capacity (FVC)

    Baseline and 6 weeks

  • Forced Expiratory Volume 1 second (FEV1)

    Baseline and 6 weeks

  • Forced Expiratory Volume 1 second / Forced Vital Capacity (FEV1 / FVC)

    Baseline and 6 weeks

  • Forced Expiratory flow from between 25% to 75% of Vital Capacity (FMF 25-75)

    Baseline and 6 weeks

  • Peak flow rate (PEF)

    Baseline and 6 weeks

  • +22 more secondary outcomes

Study Arms (3)

NMES and Peripheral Muscle Training

EXPERIMENTAL

Neuromuscular Electrical Stimulation (NMES) and Peripheral Muscle Training NMES frequency will be 30 Hertz and the application time will be 30 minutes.Treatment will be programmed for 3 days per week. Peripheral Muscle Training will be applied by elastic band and Proprioceptive Neuromuscular Facilitation 3 times per week.The program will continue for 6 weeks.

Device: Neuromuscular Electrical StimulationOther: Peripheral Muscle Training

IMT and Peripheral Muscle Training

EXPERIMENTAL

Inspirator Muscle Training (IMT) and Peripheral Muscle Training IMT will be applied 7 days per week, twice a day for 15 minutes. Peripheral Muscle Training will be applied by elastic band and Proprioceptive Neuromuscular Facilitation 3 times per week. The program will continue for 6 weeks.

Other: Inspirator Muscle TrainingOther: Peripheral Muscle Training

Peripheral Muscle Training

EXPERIMENTAL

Peripheral Muscle Training Peripheral Muscle Training will be applied by elastic band and Proprioceptive Neuromuscular Facilitation 3 times per week.The program will continue for 6 weeks.

Other: Peripheral Muscle Training

Interventions

Neuromuscular Electrical Stimulation(NMES) to rectus abdominis will be applied using 4 carbon silicon electrode. In the first sessions, patients ECG will be checked. Patients will be in semi-fowler position (30º),with their lower limbs to be in extension and upper limbs at their sides. The NMES frequency will be at 30 Hertz and the application time will be 30 minutes. Treatment will be programmed for 3 days per week. The patients will coordinate their breath (inspiration) with the contraction which will be generated by the electrical current. The program will continue for 6 weeks.

NMES and Peripheral Muscle Training

Inspirator Muscle Training(IMT) will be applied 7 days per week, twice a day for 15 minutes. The program will continue for 6 weeks duration under weekly control of the investigator.Training intensity will set at 30% of the maximum inspiratory pressure.

IMT and Peripheral Muscle Training

Peripheral Muscle Training will be applied by elastic band and Proprioceptive Neuromuscular Facilitation 3 times per week.The program will continue for 6 weeks.

IMT and Peripheral Muscle TrainingNMES and Peripheral Muscle TrainingPeripheral Muscle Training

Eligibility Criteria

Age35 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Stable coronary artery disease with metabolic syndrome diagnosis
  • The ejection fraction(EF) = % 40 and EF \>% 40,
  • Participation to the study will be in a voluntary basis

You may not qualify if:

  • Over 80 years,
  • EF \<40% or New York Heart Association (NYHA) class III-IV
  • Chronic obstructive pulmonary disease (COPD) and respiratory tract infection,
  • Documented diagnosis of pulmonary, neurological,orthopedic, renal, hepatic, gastrointestinal, endocrine, oncologic
  • New or suspected thromboembolic events
  • Severe refractory hypertension
  • Acute myocardial infarction and pulmonary edema in the last 6 months,
  • Coronary artery revascularization attempts (percutaneous transluminal coronary angioplasty and coronary artery bypass surgery) and previous valve surgery in the last 6 months,
  • Cardiac pacemaker

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Kıymet Muammer

Istanbul, Fatih/Istanbul, 34096, Turkey (Türkiye)

Location

Related Publications (1)

  • Muammer K, Mutluay F, Demir R, Ozkan AA. Effects of peripheral and different inspiratory muscle training methods in coronary artery disease patients with metabolic syndrome: A randomized-controlled trial. Respir Med. 2020 Oct;172:106119. doi: 10.1016/j.rmed.2020.106119. Epub 2020 Aug 22.

MeSH Terms

Conditions

Metabolic SyndromeCoronary Artery Disease

Condition Hierarchy (Ancestors)

Insulin ResistanceHyperinsulinismGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesCoronary DiseaseMyocardial IschemiaHeart DiseasesCardiovascular DiseasesArteriosclerosisArterial Occlusive DiseasesVascular Diseases

Study Officials

  • Kıymet Muammer, MSc PT

    Istanbul University Cardiology Institute, Department of Physiotherapy and Rehabilitation

    PRINCIPAL INVESTIGATOR
  • Fatma Karantay Mutluay, Professor

    Medipol University, Health Sciences Faculty, Physiotherapy and Rehabilitation

    STUDY DIRECTOR
  • Rengin Demir, Professor

    Istanbul University Cardiology Institute, Department of Physiotherapy and Rehabilitation,

    STUDY CHAIR
  • Alev Arat Özkan, Professor

    Istanbul University Cardiology Institute,Catheter Laboratory

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

April 14, 2018

First Posted

May 14, 2018

Study Start

April 15, 2018

Primary Completion

November 30, 2018

Study Completion

December 30, 2018

Last Updated

January 29, 2019

Record last verified: 2018-09

Locations